Trial intelligence / Profile preview

N-Acetylcysteine vs Alpha-Lipoic Acid for Colistin-Induced Nephrotoxicity

NCT06650384Phase 3Completed

Sponsor
Ain Shams University
Start
Nov 2024
Primary completion
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acetylcysteine, alpha-lipoic acid in colistin-induced nephrotoxicity, sponsored by Ain Shams University. Started Nov 2024; status: completed.

02

Drugs

acetylcysteinealpha-lipoic acid
03

Conditions

colistin-induced nephrotoxicity

Beyond the preview

Go deeper on NCT06650384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06650384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call